Newron Pharmaceuticals SpA (NWRN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.119x

Based on the latest financial reports, Newron Pharmaceuticals SpA (NWRN) has a cash flow conversion efficiency ratio of 0.119x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-1.33 Million ≈ $-1.68 Million USD) by net assets (CHF-11.13 Million ≈ $-14.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Newron Pharmaceuticals SpA (NWRN) balance sheet quality index to measure how much of total assets are equity-financed.

Newron Pharmaceuticals SpA - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Newron Pharmaceuticals SpA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Newron Pharmaceuticals SpA to evaluate the quality of earnings relative to operating cash generation.

Newron Pharmaceuticals SpA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Newron Pharmaceuticals SpA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Wanxiang Doneed Co Ltd SHG:600371	-0.012x
Shanghai Fenghwa Group Co Ltd SHG:600615	0.004x
Profit Cultural & Creative Group Co Ltd SHE:300640	-0.018x
The Metals Royalty Company Inc. Common Stock NASDAQ:TMCR	-0.095x
Sonda S.A SN:SONDA	0.054x
Sarawak Plantation Bhd KLSE:5135	0.051x
Organogenesis Holdings Inc NASDAQ:ORGO	0.008x
Lagenda Properties Bhd KLSE:7179	0.036x

Annual Cash Flow Conversion Efficiency for Newron Pharmaceuticals SpA (2005–2025)

The table below shows the annual cash flow conversion efficiency of Newron Pharmaceuticals SpA from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Newron Pharmaceuticals SpA worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF-11.13 Million ≈ $-14.07 Million	CHF32.56 Million ≈ $41.17 Million	-2.926x	+75.78%
2024-12-31	CHF1.46 Million ≈ $1.84 Million	CHF-17.61 Million ≈ $-22.27 Million	-12.081x	-3663.28%
2023-12-31	CHF-29.91 Million ≈ $-37.81 Million	CHF-10.14 Million ≈ $-12.82 Million	0.339x	-57.12%
2022-12-31	CHF-14.03 Million ≈ $-17.74 Million	CHF-11.09 Million ≈ $-14.02 Million	0.791x	+121.46%
2021-12-31	CHF3.11 Million ≈ $3.93 Million	CHF-11.45 Million ≈ $-14.47 Million	-3.684x	-307.54%
2020-12-31	CHF17.25 Million ≈ $21.80 Million	CHF-15.59 Million ≈ $-19.71 Million	-0.904x	-51.35%
2019-12-31	CHF36.80 Million ≈ $46.52 Million	CHF-21.98 Million ≈ $-27.78 Million	-0.597x	-105.27%
2018-12-31	CHF54.84 Million ≈ $69.33 Million	CHF-15.95 Million ≈ $-20.17 Million	-0.291x	-134.45%
2017-12-31	CHF67.72 Million ≈ $85.62 Million	CHF-8.40 Million ≈ $-10.62 Million	-0.124x	+68.48%
2016-12-31	CHF49.75 Million ≈ $62.89 Million	CHF-19.58 Million ≈ $-24.76 Million	-0.394x	-13.58%
2015-12-31	CHF37.11 Million ≈ $46.92 Million	CHF-12.86 Million ≈ $-16.26 Million	-0.347x	-1.43%
2014-12-31	CHF29.26 Million ≈ $36.99 Million	CHF-10.00 Million ≈ $-12.64 Million	-0.342x	+32.56%
2013-12-31	CHF21.09 Million ≈ $26.66 Million	CHF-10.69 Million ≈ $-13.51 Million	-0.507x	-340.15%
2012-12-31	CHF27.61 Million ≈ $34.90 Million	CHF5.83 Million ≈ $7.36 Million	0.211x	+128.11%
2011-12-31	CHF6.58 Million ≈ $8.33 Million	CHF-4.94 Million ≈ $-6.25 Million	-0.750x	+52.17%
2010-12-31	CHF12.19 Million ≈ $15.41 Million	CHF-19.13 Million ≈ $-24.18 Million	-1.569x	-99.27%
2009-12-31	CHF29.28 Million ≈ $37.02 Million	CHF-23.06 Million ≈ $-29.15 Million	-0.787x	-80.96%
2008-12-31	CHF45.81 Million ≈ $57.92 Million	CHF-19.93 Million ≈ $-25.20 Million	-0.435x	-80.11%
2007-12-31	CHF57.40 Million ≈ $72.57 Million	CHF-13.87 Million ≈ $-17.53 Million	-0.242x	-70.22%
2006-12-31	CHF67.86 Million ≈ $85.79 Million	CHF-9.63 Million ≈ $-12.17 Million	-0.142x	+83.14%
2005-12-31	CHF17.02 Million ≈ $21.52 Million	CHF-14.33 Million ≈ $-18.12 Million	-0.842x	--

About Newron Pharmaceuticals SpA

SW:NWRN Switzerland Biotechnology

Market Cap

$305.13 Million

CHF241.35 Million CHF

Market Cap Rank

#14820 Global

#156 in Switzerland

Share Price

CHF11.60

Change (1 day)

-0.51%

52-Week Range

CHF6.89 - CHF30.40

All Time High

CHF30.40